David E. Lazar - 06 Jul 2022 Form 3 Insider Report for TITAN PHARMACEUTICALS INC (TTNP)

Role
10%+ Owner
Signature
/s/ David E. Lazar
Issuer symbol
TTNP
Transactions as of
06 Jul 2022
Net transactions value
$0
Form type
3
Filing time
08 Jul 2022, 18:00:19 UTC
Next filing
26 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TTNP Common Stock, par value $0.001 1,421,133 06 Jul 2022 Direct F1
holding TTNP Common Stock, par value $0.001 43,145 06 Jul 2022 By Activist Investing LLC F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 3 is filed jointly by Activist Investing LLC ("Activist Investing") and David E. Lazar (collectively, the "Reporting Persons").
F2 Securities of Titan Pharmaceuticals, Inc. (the "Issuer") beneficially owned directly by Activist Investing. Mr. Lazar, as the sole member and Chief Executive Officer of Activist Investing, may be deemed the beneficial owner of the securities of the Issuer beneficially owned by Activist Investing.
F3 Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.